NAFLD, but there are distinct differences in the microscopic appearance in many pediatric cases. Specifically, children with fatty liver disease may have more steatosis, fewer ballooned hepatocytes, and more portal-based inflammation and/or fibrosis. 3 Studies of steatosis in the context of NASH to date have focused largely on the amount of steatosis. For example, in a study in adults with NAFLD from the National Institute of Diabetes and Digestive and Kidney Diseases Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN), Neuschwander-Tetri et al 4 found that those with moderate and severe steatosis were more likely to have NASH than those with only mild steatosis. In addition, in a study of children from the NASH CRN, children with hypertension tended to have more steatosis compared with those who were normotensive. 5 Another study of adults with NAFLD showed that those with type 2 diabetes had more severe steatosis on histology compared with those without diabetes. 6 In addition to the percentage of hepatocytes with steatosis, steatosis can be categorized based on the hepatic zones in which fat droplets are present. Fat accumulation in hepatocytes may be microscopically subdivided in 4 distributions, regardless of amount: (1) panacinar (even distribution), (2) zone 1 (periportal), (3) zone 3 (centrilobular or pericentral), and (4) azonal (uneven distribution) ( Figure 1) . Previous research has shown that in adults with NAFLD, inflammation and fibrosis tend to be in zone 3 and not in zone 1. This is in contrast to children, in which inflammation and fibrosis are often present in zone 1, but can be seen in zone 3. Much less is known about the localization of steatosis in NAFLD than the localization of inflammation or fibrosis. Previous studies have shown about 10% of children have accentuation of steatosis in periportal, or zone 1, hepatocytes, 3, 7, 8 whereas, zone 1 steatosis is uncommon in adults with NAFLD. 8, 9 Thus, clinical correlates of zone 1 versus zone 3 steatosis are relatively unexplored, and to do so would require a large population of children with biopsy-proven NAFLD. The National Institutes of Health NASH CRN provides such a cohort because biopsy evaluation includes localization and amount of steatosis. We therefore performed a multicenter, cross-sectional cohort study from this cohort with the aim of determining associations between zone 1 and zone 3 localizations of steatosis and demographic, clinical, and other histologic features in children with NAFLD.
Methods

Study Population
We included children <18 years of age with NAFLD enrolled in the NASH CRN who were participants in 1 of the following studies: the longitudinal cohort studies Database and Database 2 (NCT01061684) or the randomized controlled trials Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC; NCT00063635) or Cysteamine Bitartrate Delayed-Release for the Treatment of Non-alcoholic Fatty Liver Disease in Children (CyNCh; NCT01529268). The diagnosis of NAFLD was based on !5% of hepatocytes containing macrovesicular fat and exclusion of other causes of chronic liver disease based on clinical history, laboratory studies, and histology. 8 The institutional review board at each participating center approved these studies. Written consent was obtained from each participant's parent or guardian, and written assent was obtained from each participant age 8 and older.
History and Physical Examination
Demographic data and clinical history were obtained via a structured interview developed by the NASH CRN. Weight and height were measured to the nearest 0.1 kg and 0.1 cm, respectively. Body mass index (BMI) was calculated as weight (kg) per height (m) squared. BMI z score was calculated to account for age and sex and based on Centers for Disease Control and Prevention reference standards. 
Laboratory Studies
Participants fasted for 12 hours before collection of blood via venipuncture. Laboratory assays included aspartate aminotransferase (AST), alanine aminotransferase (ALT), g-glutamyltransferase, total cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides, hemoglobin A 1C , serum glucose, and serum insulin.
Liver Histology
The Pathology Committee of the NASH CRN reviewed hematoxylin-eosin and trichrome stained slides in consensus conference according to the NASH CRN scoring system. 8 The pathologists were unaware of the clinical study, age, gender, or other clinical features of the children at the time of review, including whether the biopsy was from a child or adult. Biopsies were given a score for degree of steatosis based on the following: grade 0 (none to <5%), grade 1 (5%-33%), grade 2 (34%-66%), and grade 3 (>66%). Lobular inflammation was categorized based on the assessment of all inflammatory foci: no foci, <2 foci per Â200 field, 2-4 foci per Â200 field, and >4 foci per Â200. Portal inflammation was categorized into 3 groups: (1) none, (2) mild, and (3) more than mild. Ballooning was categorized into 3 groups: (1) none, (2) few, and (3) many. Fibrosis was staged based on the following: stage 0 (no fibrosis), stage 1a (mild zone 3 perisinusoidal requiring trichrome stain), stage 1b (moderate zone 3 perisinusoidal fibrosis not requiring trichrome stain), stage 1c (portal/periportal fibrosis only), stage 2 (zone 3 perisinusoidal and periportal), stage 3 (bridging fibrosis), and stage 4 (cirrhosis). An overall diagnosis was made based on the composite features of the biopsy, but without regard to NAFLD Activity Score, according to the following categories: NAFLD not NASH, borderline zone 1 NASH, borderline zone 3 NASH, and definite NASH. Location of steatosis was noted as follows: zone 1 (periportal), zone 3 (perivenular), panacinar, and azonal. Azonal (irregular) distribution of fat droplets was assigned to cases in 2 circumstances: when clear zone 1, zone 3, or uniform panacinar patterns of steatosis were not apparent; or when cirrhosis or bridging fibrosis were present, as vascular landmarks are lost. Panacinar steatosis was recorded when there was an even distribution, regardless of amount, throughout the lobule and with no predilection for, or sparing of zones. The NAFLD Activity Score was subsequently calculated from the scores assigned for steatosis amount, lobular inflammation, and ballooning, as described. 8 
Data Analysis
For this analysis, only cases with pure zone 1 and zone 3 steatosis were compared. The demographic, clinical, and histopathologic characteristics of all children included in this study were reported using standard descriptive statistics. Children were divided into 2 groups for analysis: those with zone 1 steatosis and those with zone 3 steatosis. For continuous variables, sample mean, standard deviation, and 95% confidence interval (CI) were calculated. Wilcoxon rank test and 2-sample Student t test were used to compare demographic and laboratory continuous parameters among the 2 groups. For categorical variables, frequency and percentages were computed. Chi-square test was used to compare differences between the groups for binary categorical variables. Mantel-Haenszel chi-square test was used to compare differences between the groups for ordinal categorical variables. Demographic factors influencing the presence of zone 1 and zone 3 steatosis were identified using multinomial logistic regression models, with presence of zone 1 and zone 3 as primary outcomes and candidate factors: age, sex, ethnicity, and BMI z score. Goodness of fit of the first logistic regression model (zone 1 vs other distributions) was assessed using a Hosmer-Lemeshow chi-square test with P > .05 indicating adequate fit. The likelihood ratio test, Score test, and Wald test assessed the fit of the model compared with an empty model. Parallel analysis was done with the second logistic regression model (zone 3 vs other distributions). Analyses were performed using R version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Study Population
There were 813 children enrolled in the NASH CRN. Thirty-seven children were excluded because their liver biopsy results were not consistent with NAFLD. In the remaining 776 children, the zonality of steatosis in the liver biopsies was distributed as follows: zone 1 ¼ 146 (19%), zone 3 ¼ 244 (31%), azonal ¼ 59 (8%), and panacinar ¼ 327 (42%). The remainder of data pertain to zone 1 and zone 3 steatosis cohorts; data for the panacinar and azonal cohorts are available in Supplementary Tables 1 and 2 .
Demographic and Clinical Differences Between Zone 1 and Zone 3 Steatosis Cohorts
Demographic and clinical parameters are shown in Table 1 for the 390 children with zone 1 or zone 3 steatosis. As shown in Figure 2 , children with zone 1 steatosis were younger than children with zone 3 steatosis (mean age, 10.8 [standard deviation, 2.1] vs 14.7 [standard deviation, 2.1] years; P < .001). Children with zone 1 steatosis were more likely to be Hispanic (75% vs 58%; P ¼ .001) than those with zone 3 steatosis. Children with zone 1 steatosis had higher fasting triglyceride levels (164 mg/dL vs 125 mg/dL; P < .001) and lower fasting insulin (25 mU/mL vs 39 mU/mL; P < .001) than those with zone 3 steatosis. There was no significant difference in sex between children with zone 1 and zone 3 steatosis. Height, weight, and BMI were all significantly different between zonality group, but BMI z score was not. Children with zone 3 steatosis had higher waist circumference (109.5 cm vs 96.4 cm; P < .001), systolic blood pressure (125 mm Hg vs 115 mm Hg; P < .001), and diastolic blood pressure (70 mm Hg vs 65 mm Hg; P < .001) than those with zone 1 steatosis. There were no significant differences in ALT or g-glutamyltransferase between groups, but there was a small but significant difference in AST, with those in zone 1 steatosis group having higher AST (56 U/L vs 52 U/L; P ¼ .017).
Histologic Differences Between Zone 1 and Zone 3 Steatosis
As shown in Table 2 , there were distinct histologic differences between the zone 1 and zone 3 steatosis groups, although the grades of steatosis did not differ for children with zone 1 or zone 3 steatosis. Biopsies with zone 3 steatosis had more ballooning compared with those with zone 1 steatosis (48% vs 29%; P < .001), higher NAFLD Activity Score (4.1 vs 3.7; P ¼ .014), and a greater frequency of a diagnosis of definite NASH than biopsies with zone 1 steatosis (30% vs 6%; P < .001). Biopsies with zone 1 steatosis had more portal inflammation than those with zone 3 steatosis (97% vs 75%; Children with zone 1 steatosis were significantly younger than children with zone 3 steatosis (P < .0001).
P < .001). In univariate analysis, biopsies with zone 1 steatosis compared with biopsies with zone 3 steatosis had more fibrosis of any grade (80% vs 51%) and more advanced fibrosis (13% vs 5%; P < .001). In a multivariate logistic regression model, after controlling for age, sex, and BMI z score, children with zone 1 steatosis had 2.34 times the odds of having advanced fibrosis than children with zone 3 steatosis (95% CI, 1.03-5.52).
Logistic Regression Model for Zone 1 and Zone 3 Steatosis
Among all children with NAFLD, the only independent risk factor identified for having zone 1 steatosis was age. Specifically, children <13 years had 6.3 (95% CI, 3.9-10.4) times the odds of having zone 1 steatosis compared with children !13 years. In contrast, both age and sex were significant independent risk factors for having zone 3 steatosis. Thus, children with NAFLD who were !13 years had 9.0 (95% CI, 6.3-13.2) times the odds of having zone 3 steatosis compared with children <13 years. In addition, girls with NAFLD had 1.6 (95% CI, 1.1-2.3) times the odds of having zone 3 steatosis compared with boys with NAFLD. Ethnicity and BMI z score did not improve the fit of the model for either zone 1 or one 3 steatosis.
Subanalysis of Zone 3 Steatosis With Either Zone 1 or Zone 3 Fibrosis
Within the defined patterns of zonality of steatosis, there was a noted distribution of fibrosis, central/perisinusoidal and portal. As shown in Table 2 , 94 (64%) biopsies with zone 1 steatosis had fibrosis that colocalized with the steatosis, with only 3 (3%) in this group having central/perisinusoidal fibrosis. Thus, because of the small number, this was not analyzed further.
In contrast, for those with zone 3 steatosis, 75 (31%) had fibrosis that was zonally restricted, and 24 (32%) of these had a portal fibrosis pattern. Therefore, we further analyzed differences of fibrosis patterns among children with biopsies showing zone 3 steatosis. As shown in Table 3 , children with zone 3 steatosis and portal fibrosis were younger than those who had zone 3 steatosis with central fibrosis (14.1 vs 15.7 years; P ¼ .0142). In addition, there was a significant difference in ALT, with the central fibrosis group having higher mean ALT than the portal fibrosis group (97 U/L vs 56 U/L; P ¼ .0003). As expected, the portal fibrosis group had significantly more portal inflammation than the central fibrosis group (92% vs 78%; P ¼ .0112). There were also more children in the central fibrosis group with a diagnosis of definite NASH (55% vs 8%) and borderline zone 3 NASH (43% vs 12.5%) than the portal fibrosis group. There were more children in the portal fibrosis group that had borderline zone 1 NASH (17% vs 0%; P < .0001). There were no significant differences in sex, ethnicity, BMI z score, or steatosis grade between central and portal fibrosis groups.
Discussion
We studied the zonal distribution of hepatic steatosis in a large cohort study of children with NAFLD from pediatric centers across the United States. Steatosis was confined to zone 1 or zone 3 in approximately half of biopsies with NAFLD. Age and sex were the major demographic characteristics that were associated with the zonal location of steatosis. Children with zone 1 steatosis were younger and more likely to be boys by logistic regression. Other associations with zone 1 steatosis were Hispanic ethnicity, higher AST and triglyceride levels, and lower insulin levels. Finally, biopsies with zone 1 steatosis were more likely to have fibrosis. In contrast, biopsies from children with zone 3 steatosis more frequently showed ballooning and were more likely to be diagnosed as definite NASH.
This cross-sectional study affirms the importance of steatosis zonality in the characterization of pediatric NAFLD. To distinguish classically described steatohepatitis 10,11 from a newly recognized pediatric zone 1 pattern, Schwimmer et al 3 characterized zone-3-predominant disease as type 1 NASH and the zone-1-predominant pattern as type 2 NASH. In the current study, those children whose biopsies had zone 3 steatosis were similar to children with type 1 NASH, namely older and less likely to be boys, whereas those with zone 1 steatosis were similar to the children categorized as type 2 NASH, namely younger and with greater male predominance. These differences in zonality may have clinical implications, associated with alterations in insulin levels and triglyceride concentrations, and also possibly advanced fibrosis that can ultimately result in worsening liver function.
The hedgehog and Wnt/b-catenin pathways may explain localization of steatosis to zone 1 and zone 3. The hedgehog pathway has higher activity in young children and lower activity in adulthood and has high activity in the portal/periportal region. [12] [13] [14] This pathway is implicated in the development of fibrosis and cirrhosis in both animals and humans.
14 This is in contrast to the Wnt/b-catenin pathway, which becomes more active with age, very low in early development and more active in adulthood. 15 This pathway has the highest canonical activity around the terminal hepatic venules and governs pathways involving glutamine synthesis, drug metabolism, bile acid, and heme synthesis. 16 In addition, it is involved in hepatic development, regeneration, and response to oxidative stress. In murine models, pericentral steatosis with periportal sparing was found in b-catenin transgenic mice given a high-fat diet, whereas b-catenin knockout mice had periportal steatosis with perivenous sparing. 17, 18 The presence of zone 1 steatosis in younger patients could relate to immature or absent b-catenin pathway activity, while hedgehog pathway activity may be a potential clue why fibrosis was more common among children with zone 1 steatosis. These pathways may be potential targets of therapy.
In our study, children with zone 3 steatosis were older and had higher circulating insulin levels compared with those with zone 1 steatosis. Increased fasting insulin levels are often seen with metabolic syndrome. In the setting of metabolic syndrome, hepatocytes in zone 3 increasingly engage in glycolysis and de novo lipogenesis resulting in a higher presence of zone 3 steatosis given that the activity of specific enzymes involved in de novo lipogenesis, such as ATP citrate lyase, acetyl-CoA carboxylase, and fatty acid synthase, are higher in zone 3 hepatocytes. 19, 20 There is also higher expression of triacylglycerol synthetic enzyme, triacylglycerol hydrolase, in zone 3 hepatocytes. 21, 22 We therefore speculate that these findings may indicate that the zone 3 steatosis pattern may be consistent with higher zone 3 de novo lipogenesis and lower very-low-density lipoprotein export.
Importantly, localization of the fat droplets in the liver requires histology. Although AST levels were statistically different between children with zone 1 and zone 3 steatosis, the difference observed was not sufficient to allow stratification of steatosis by zone. There were statistically significant differences with waist circumference and blood pressure as well, although both of these are intimately related to age; older children have higher waist circumferences and blood pressures. Also of note, there was no relationship between the severity of steatosis and the zonality of fat, making current imaging modalities unhelpful for this characterization. Clinically, there may be a reluctance to perform biopsies on children suspected to have NAFLD, although liver biopsies are safe and can help in the diagnosis of NASH and other causes of hepatitis with hepatic steatosis. 23 In post hoc analysis of a recent study by the NASH CRN, there was significant histologic improvement in children with borderline zone 1 NASH compared with placebo. This is in contrast to those with other types of NASH, showing that there may be a difference in response to treatment based on zonation. 24 Hence, there are potential implications for the utility of biopsies for individual patients.
The characterization of subphenotypes of NAFLD based on zonality of steatosis is strengthened by the use of the NASH CRN, the largest prospective cohort of children with NAFLD in the United States. The diagnosis of NAFLD subtype and specification of steatosis zonality were done in a standardized fashion blinded to submitting center or patient age, along with all features of biopsy analysis by the Pathology Committee. Although the method of analysis used does not result in a final score that highlights zonality, there are 2 features of the NASH CRN pathology method that can be suggestive of a pediatric pattern of NAFLD: the portal-based pattern of fibrosis (1c); and the diagnostic subtype, borderline zone 1. In this study, a subset of children had steatosis and fibrosis in different zones. It remains unclear how zonation of steatosis, along with inflammation and the development of fibrosis, change over time because of the cross-sectional nature of this study. Longitudinal studies are important to address questions regarding the development and the stability or instability of steatosis localization.
Conclusions
Zone 1 and zone 3 steatosis are 2 distinct subphenotypes of pediatric NAFLD that may be informative of risk differences in the progression of NAFLD, namely in terms of advanced fibrosis and steatohepatitis, respectively. Further work is needed to analyze the natural history and long-term outcomes associated with these steatosis zonality patterns as children grow and develop. A better understanding of the pathophysiologic differences between these steatosis zonality patterns may provide opportunities for targeted personalized therapies for children with NAFLD in the future.
